section name header

Indications ⬇

REMS


Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Derm: acne, photosensitivity, rash

GI: anorexia, diarrhea, HEPATOTOXICITY, nausea, vomiting

GU: dysuria

Hemat: anemia, thrombocytopenia

Metab: hyperuricemia

MS: arthralgia, gouty arthritis

Interactions ⬆ ⬇

Drug-drug:

Availability ⬆ ⬇

(Generic available)

Route/Dosage ⬆ ⬇

Action ⬆ ⬇

  • Converted to pyrazinoic acid in susceptible strains of Mycobacterium, which lowers the pH of the environment.
Therapeutic effects:
  • Bacteriostatic action against susceptible mycobacteria.

Spectrum:

Classifications ⬆ ⬇

Therapeutic Classification: antituberculars

Pharmacokinetics ⬆ ⬇

Absorption: Well absorbed after oral administration.

Distribution: Widely distributed to tissues. Reaches high concentrations in the CNS (same as plasma).

Metabolism/Excretion: Mostly metabolized by the liver. Metabolite (pyrazinoic acid) has antimycobacterial activity; 3–4% excreted unchanged by the kidneys.

Half-Life: Pyrazinamide: 9.5 hr. Pyrazinoic acid: 12 hr. Both are ↑ in renal impairment.

Time/Action Profile ⬆ ⬇

(plasma concentrations)

ROUTEONSETPEAKDURATION
POunknown1–2 hr (4–5 hr‡)24 hr

‡For pyrazinoic acid.

Patient/Family Teaching ⬆ ⬇

Pronunciation ⬆ ⬇

peer-a-ZIN-a-mide

Code ⬆

NDC Code